Press release
BK virus (BKV) Infection Pipeline Drugs and Companies Insight Report (2022): Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments
BK virus (BKV) Infection Overview
BK virus (BKV) Infection- The BK virus was first isolated from the urine of a renal transplant recipient with ureteric stenosis in1971. BK virus is one of 13 known polyomaviruses. Antibodies to BKV are found in approximately 80 to 90 percent of adults worldwide, indicating previous infection or exposure to the virus. Initial infection with BKV is usually asymptomatic or associated with a mild flu-like illness.
"BK virus (BKV) Infection Pipeline Insight, 2022" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the BK virus (BKV) Infection Market.
The BK virus (BKV) Infection Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the BK virus (BKV) Infection Pipeline Report: https://www.delveinsight.com/report-store/bk-virus-bkv-infection-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel BK virus (BKV) Infection treatment therapies with a considerable amount of success over the years. BK virus (BKV) Infection Key players such as - Memo Therapeutics, Hybridize Therapeutics, SL VAXiGEN, Vera Therapeutics, AlloVir, and others, are developing therapies for the BK virus (BKV) Infection treatment
• BK virus (BKV) Infection Emerging therapies such as - MTX-005, HYB-BKV, SL-V10, MAU868, Viralym-M (ALVR105), and others are expected to have a significant impact on the BK virus (BKV) Infection market in the coming years.
• In March 2021, AlloVir initiated a Phase III study to evaluate ALVR105 (Viralym-M); an allogeneic, off the-shelf multi-virus specific T cell therapy that targets six viral pathogens: BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6 and JC virus.
• In October 2021, the US Food and drug administration (FDA) granted Orphan Drug Designation (ODD) to posoleucel (Viralym-M, ALVR105) for the treatment of virus-associated hemorrhagic cystitis (HC). In June 2019, ALVR 105 received Regenerative Medicine Advanced Therapy (RMAT) designation from the US FDA for Viralym-M (ALVR105), a lead allogeneic, off-the-shelf, multi-virus specific T-cell therapy, for the treatment of hemorrhagic cystitis (HC) caused by BK virus in adults and children following allogeneic hematopoietic stem cell transplantation (HSCT)
BK virus (BKV) Infection Pipeline Therapeutics Assessment
• BK virus (BKV) Infection Assessment by Product Type
• BK virus (BKV) Infection By Stage and Product Type
• BK virus (BKV) Infection Assessment by Route of Administration
• BK virus (BKV) Infection By Stage and Route of Administration
• BK virus (BKV) Infection Assessment by Molecule Type
• BK virus (BKV) Infection by Stage and Molecule Type
DelveInsight's BK virus (BKV) Infection Report covers around 4+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Emerging BK virus (BKV) Infection Drugs Under Different Phases of Clinical Development Include:
• MTX-005: Memo Therapeutics
• HYB-BKV: Hybridize Therapeutics
• SL-V10: SL VAXiGEN
• MAU868: Vera Therapeutics
• Viralym-M (ALVR105): AlloVir
Get a Free Sample PDF Report to know more about BK virus (BKV) Infection Pipeline Assessment- https://www.delveinsight.com/sample-request/bk-virus-bkv-infection-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
BK virus (BKV) Infection Pipeline Analysis:
The BK virus (BKV) Infection pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the BK virus (BKV) Infection treatment with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for BK virus (BKV) Infection Treatment.
• BK virus (BKV) Infection key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• BK virus (BKV) Infection Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the BK virus (BKV) Infection market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Further BK virus (BKV) Infection product details are provided in the report. Download the BK virus (BKV) Infection pipeline report to learn more about the emerging BK virus (BKV) Infection therapies at:
https://www.delveinsight.com/sample-request/bk-virus-bkv-infection-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
BK virus (BKV) Infection Pipeline Market Drivers
• Increase in the number of patients requiring kidney transplant worldwide
• Technological and medical advancements
• Guidelines supporting early detection and prompt diagnosis
BK virus (BKV) Infection Pipeline Market Barriers
• Lack of effective treatment options against BK virus infection
• Biology of BKPyV is not completely understood
• Side effects associated with the current treatment options
Scope of BK virus (BKV) Infection Pipeline Drug Insight
• Coverage: Global
• Key BK virus (BKV) Infection Companies: , and others
• Key BK virus (BKV) Infection Therapies: MTX-005, HYB-BKV, SL-V10, MAU868, Viralym-M (ALVR105), and others
• BK virus (BKV) Infection Therapeutic Assessment: BK virus (BKV) Infection current marketed and BK virus (BKV) Infection emerging therapies
• BK virus (BKV) Infection Market Dynamics: BK virus (BKV) Infection market drivers and BK virus (BKV) Infection market barriers
Request for Sample PDF Report for BK virus (BKV) Infection Pipeline Assessment and clinical trials- https://www.delveinsight.com/sample-request/bk-virus-bkv-infection-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1 BK virus (BKV) Infection Report Introduction
2 BK virus (BKV) Infection Executive Summary
3 BK virus (BKV) Infection Overview
4 BK virus (BKV) Infection- Analytical Perspective In-depth Commercial Assessment
5 BK virus (BKV) Infection Pipeline Therapeutics
6 BK virus (BKV) Infection Late Stage Products (Phase II/III)
7 BK virus (BKV) Infection Mid Stage Products (Phase II)
8 BK virus (BKV) Infection Early Stage Products (Phase I)
9 BK virus (BKV) Infection Preclinical Stage Products
10 BK virus (BKV) Infection Therapeutics Assessment
11 BK virus (BKV) Infection Inactive Products
12 Company-University Collaborations (Licensing/Partnering) Analysis
13 BK virus (BKV) Infection Key Companies
14 BK virus (BKV) Infection Key Products
15 BK virus (BKV) Infection Unmet Needs
16 BK virus (BKV) Infection Market Drivers and Barriers
17 BK virus (BKV) Infection Future Perspectives and Conclusion
18 BK virus (BKV) Infection Analyst Views
19 Appendix
20 About DelveInsight
Download Sample PDF Report to know more about BK virus (BKV) Infection drugs and therapies- https://www.delveinsight.com/sample-request/bk-virus-bkv-infection-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Related Reports:
BK virus (BKV) Infection Market https://www.delveinsight.com/report-store/bk-virus-bkv-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'BK virus (BKV) Infection-Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),
BK virus (BKV) Infection Epidemiology https://www.delveinsight.com/report-store/bk-virus-bkv-infection-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'BK virus (BKV) Infection Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports:
Ventricular Assist Devices Market https://www.delveinsight.com/report-store/ventricular-assist-devices-vad-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"DelveInsight's 'Ventricular Assist Devices (VAD) Market Insight, Competitive Landscape and Market Forecast - 2027' report delivers an in-depth understanding of Ventricular Assist Devices and the historical and forecasted Ventricular Assist Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Vein Illumination Devices Market https://www.delveinsight.com/report-store/vein-illumination-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Vein Illumination Devices - Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Basal Cell Carcinoma (Basal Cell Epithelioma) Market
https://www.delveinsight.com/report-store/basal-cell-carcinoma-basal-cell-epithelioma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Basal Cell Carcinoma (Basal Cell Epithelioma) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Basal Cell Carcinoma (Basal Cell Epithelioma), historical and forecasted epidemiology as well as the Basal Cell Carcinoma (Basal Cell Epithelioma) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Contact Us:
Gaurav Bora
gbora@delveinsight.com
+1(919)321-6187
www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release BK virus (BKV) Infection Pipeline Drugs and Companies Insight Report (2022): Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments here
News-ID: 2832372 • Views: …
More Releases from DelveInsight Business Research
Global Tumor Ablation Market to reach USD 4,595.68 million by 2032 at a CAGR of …
According to DelveInsight's analysis, The global Tumor Ablations (EHR) market is experiencing significant growth, driven by the increasing prevalence of chronic diseases that require continuous monitoring, data management, and coordinated long-term care. This demand has fueled the need for integrated healthcare systems capable of connecting patient information across multiple departments and care settings. To support this trend, governments worldwide are introducing initiatives, funding, mandates, and regulatory frameworks to promote EHR…
Global Spinal Implants Market to reach USD 21,899.24 million by 2032 at a CAGR o …
According to DelveInsight's analysis, The increasing prevalence of spinal disorders, especially among the aging population, has substantially driven the demand for corrective surgical procedures. At the same time, the rise in sports-related and trauma-induced spinal injuries is boosting the need for advanced implantable solutions. Additionally, there is a growing preference for non-fusion and motion-preserving devices that maintain spinal mobility and improve patient outcomes, particularly among younger and more active individuals.…
Global Vascular Stents Market to reach USD 18,277.68 million by 2032 at a CAGR o …
According to DelveInsight's analysis, The increasing global incidence of cancer is boosting the demand for effective treatment options such as tumor ablation. Minimally invasive procedures are becoming more popular due to their shorter recovery periods, reduced risks, and cost-effectiveness compared to conventional surgery. At the same time, technological advancements in tumor ablation devices-such as improvements in radiofrequency, microwave, and cryoablation technologies-have enhanced precision, safety, and effectiveness, making these procedures increasingly…
Global Vascular Grafts Market to reach USD 3,153.39 million by 2032 at a CAGR of …
According to DelveInsight's analysis, The increasing prevalence of cardiovascular disorders, along with risk factors like hypertension, diabetes, and obesity, is fueling the demand for surgical interventions, thereby supporting the growth of the vascular graft market. Moreover, greater awareness and the expansion of cardiovascular screening programs are enabling earlier diagnosis and timely treatment, further driving the need for vascular grafts.
DelveInsight's "Vascular Grafts Market Insights, Competitive Landscape and Market Forecast-2032" report provides…
More Releases for BKV
BK Virus (BKV) Infection Market Deep Research Report with Forecast to 2032 | All …
The BK Virus (BKV) infection market is estimated to be valued at USD 48.3 Mn in 2025 and is expected to reach USD 559.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 41.9% from 2025 to 2032.
The BK Virus (BKV) Infection Market research report not only assists newly entered businesses but also assists businesses of all levels, shapes, scope, experience levels and sizes. This report also…
BKV Infection Therapeutics Market Size in the 7MM is expected to grow by 2034, e …
DelveInsight's "BK Virus Infection Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of BK Virus Infection, historical and forecasted epidemiology as well as the BK Virus Infection market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
Unlock key insights into the BKV Infection Market! Download DelveInsight's comprehensive report to explore market trends, pipeline analysis, and emerging therapies…
BK Virus (BKV) Infection Market Projected CAGR 41.7%, Growth Insights Industry T …
According to a new report published by CoherentMI The BK Virus (BKV) infection market is estimated to be valued at USD 34 Mn in 2024 and is expected to reach USD 389 Mn by 2031, growing at a compound annual growth rate (CAGR) of 41.7% from 2024 to 2031.
The Global BK Virus (BKV) Infection Market has recently been analyzed and explored by CoherentMI in their latest market research report.…
BK Virus (BKV) Infection Market Industry Overview, Size, and Growth Insights Rep …
A new Report by CoherentMI Market Reports, titled "BK Virus (BKV) Infection Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031,"" offers a comprehensive analysis of the industry, which comprises insights on the BK Virus (BKV) Infection market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The BK Virus (BKV) infection market is estimated to be valued at USD 34 Mn in 2024…
BK virus (BKV) Infection Market to witness growth by 2032, estimates DelveInsigh …
(Albany, USA) DelveInsight's "BK virus (BKV) Infection Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of BK virus (BKV) Infection, historical and forecasted epidemiology as well as the BK virus (BKV) Infection market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The BK virus (BKV) Infection market report provides current treatment practices, emerging drugs, the market share of the individual…
Advertising Agencie Service Market Statistical Forecast, Trade Analysis 2022 -WP …
The Advertising Agencie Service report is an in-depth examination of the global Advertising Agencie Service's general consumption structure, development trends, sales techniques, and top nations' sales. The research looks at well-known providers in the global Advertising Agencie Service industry, as well as market segmentation, competition, and the macroeconomic climate. A complete Advertising Agencie Service analysis takes into account a number of aspects, including a country's population and business cycles, as…
